Search

Your search keyword '"Suraokar, Milind"' showing total 153 results
Start Over Author "Suraokar, Milind"
153 results on '"Suraokar, Milind"'

2. Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors

Author

Dalvi, Maithili P., Wang, Lei, Zhong, Rui, Kollipara, Rahul K., Park, Hyunsil, Bayo, Juan, Yenerall, Paul, Zhou, Yunyun, Timmons, Brenda C., Rodriguez-Canales, Jaime, Behrens, Carmen, Mino, Barbara, Villalobos, Pamela, Parra, Edwin R., Suraokar, Milind, Pataer, Apar, Swisher, Stephen G., Kalhor, Neda, Bhanu, Natarajan V., Garcia, Benjamin A., Heymach, John V., Coombes, Kevin, Xie, Yang, Girard, Luc, Gazdar, Adi F., Kittler, Ralf, Wistuba, Ignacio I., Minna, John D., and Martinez, Elisabeth D.

Published
2017
Full Text
View/download PDF

3. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network

Author

Tan, Xiaochao, Banerjee, Priyam, Liu, Xin, Yu, Jiang, Gibbons, Don L., Wu, Ping, Scott, Kenneth L., Diao, Lixia, Zheng, Xiaofeng, Wang, Jing, Jalali, Ali, Suraokar, Milind, Fujimoto, Junya, Behrens, Carmen, Liu, Xiuping, Liu, Chang-gong, Creighton, Chad J., Wistuba, Ignacio I., and Kurie, Jonathan M.

Subjects
Lung cancer -- Development and progression -- Prognosis, MicroRNA -- Health aspects -- Physiological aspects, Cancer metastasis -- Genetic aspects -- Development and progression, Transcription factors -- Health aspects, Health care industry
Abstract

Epithelial tumor cells undergo epithelial-to-mesenchymal transition (EMT) to gain metastatic activity. Competing endogenous RNAs (ceRNAs) have binding sites for a common set of microRNAs (miRs) and regulate each other's expression by sponging miRs. Here, we address whether ceRNAs govern metastasis driven by the EMT- activating transcription factor ZEB1. High miR-181b levels were correlated with an improved prognosis in human lung adenocarcinomas, and metastatic tumor cell lines derived from a murine lung adenocarcinoma model in which metastasis is ZEB1- driven were enriched in miR-181b targets. ZEB1 relieved a strong basal repression of [[alpha].sub.1] integrin (ITGA1) mRNA, which in turn upregulated adenylyl cyclase 9 mRNA (ADCY9) by sponging miR181b. Ectopic expression of the ITGA1 3'-untranslated region reversed miR-181b-mediated metastasis suppression and increased the levels of adenylyl cyclase 9 protein (AC9), which promoted tumor cell migration and metastasis. In human lung adenocarcinomas, ITGA1 and ADCY9 levels were positively correlated, and an AC9-activated transcriptomic signature had poor-prognostic value. Thus, ZEB1 initiates a miR-181b-regulated ceRNA network to drive metastasis., Introduction Metastasis is the primary cause of cancer-related death (1) and is driven by tumor cells that are uniquely capable of switching reversibly between epithelial and mesenchymal states in response [...]

Published
2018
Full Text
View/download PDF

4. Supplementary Table 4 from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 2 from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

6. Data from Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Author

Solis, Luisa M., primary, Behrens, Carmen, primary, Dong, Wenli, primary, Suraokar, Milind, primary, Ozburn, Natalie C., primary, Moran, Cesar A., primary, Corvalan, Alejandro H., primary, Biswal, Shyam, primary, Swisher, Stephen G., primary, Bekele, B. Nebiyou, primary, Minna, John D., primary, Stewart, David J., primary, and Wistuba, Ignacio I., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 1 from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Data from Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Author

Solis, Luisa M., primary, Behrens, Carmen, primary, Dong, Wenli, primary, Suraokar, Milind, primary, Ozburn, Natalie C., primary, Moran, Cesar A., primary, Corvalan, Alejandro H., primary, Biswal, Shyam, primary, Swisher, Stephen G., primary, Bekele, B. Nebiyou, primary, Minna, John D., primary, Stewart, David J., primary, and Wistuba, Ignacio I., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Methods, Figures 1 - 7, and Tables 1 - 6 from Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer

Author

Delgado, Oliver, primary, Batten, Kimberly G., primary, Richardson, James A., primary, Xie, Xian-Jin, primary, Gazdar, Adi F., primary, Kaisani, Aadil A., primary, Girard, Luc, primary, Behrens, Carmen, primary, Suraokar, Milind, primary, Fasciani, Gail, primary, Wright, Woodring E., primary, Story, Michael D., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Shay, Jerry W., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figures 1 - 6 from VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy

Author

Riquelme, Erick, primary, Suraokar, Milind, primary, Behrens, Carmen, primary, Lin, Heather Y., primary, Girard, Luc, primary, Nilsson, Monique B., primary, Simon, George, primary, Wang, Jing, primary, Coombes, Kevin R., primary, Lee, J. Jack, primary, Hong, Waun Ki, primary, Heymach, John, primary, Minna, John D., primary, and Wistuba, Ignacio I., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure 1 from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 3 from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure Legends from VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy

Author

Riquelme, Erick, primary, Suraokar, Milind, primary, Behrens, Carmen, primary, Lin, Heather Y., primary, Girard, Luc, primary, Nilsson, Monique B., primary, Simon, George, primary, Wang, Jing, primary, Coombes, Kevin R., primary, Lee, J. Jack, primary, Hong, Waun Ki, primary, Heymach, John, primary, Minna, John D., primary, and Wistuba, Ignacio I., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure Legend from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Methods from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

17. SWEAVE Data from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table 2 from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Author

Tang, Hao, primary, Xiao, Guanghua, primary, Behrens, Carmen, primary, Schiller, Joan, primary, Allen, Jeffrey, primary, Chow, Chi-Wan, primary, Suraokar, Milind, primary, Corvalan, Alejandro, primary, Mao, Jianhua, primary, White, Michael A., primary, Wistuba, Ignacio I., primary, Minna, John D., primary, and Xie, Yang, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Tables 1 - 3 from VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy

Author

Riquelme, Erick, primary, Suraokar, Milind, primary, Behrens, Carmen, primary, Lin, Heather Y., primary, Girard, Luc, primary, Nilsson, Monique B., primary, Simon, George, primary, Wang, Jing, primary, Coombes, Kevin R., primary, Lee, J. Jack, primary, Hong, Waun Ki, primary, Heymach, John, primary, Minna, John D., primary, and Wistuba, Ignacio I., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure 2 from Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling

Author

Borkowski, Robert, primary, Du, Liqin, primary, Zhao, Zhenze, primary, McMillan, Elizabeth, primary, Kosti, Adam, primary, Yang, Chin-Rang, primary, Suraokar, Milind, primary, Wistuba, Ignacio I., primary, Gazdar, Adi F., primary, Minna, John D., primary, White, Michael A., primary, and Pertsemlidis, Alexander, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Materials from Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling

Author

Borkowski, Robert, primary, Du, Liqin, primary, Zhao, Zhenze, primary, McMillan, Elizabeth, primary, Kosti, Adam, primary, Yang, Chin-Rang, primary, Suraokar, Milind, primary, Wistuba, Ignacio I., primary, Gazdar, Adi F., primary, Minna, John D., primary, White, Michael A., primary, and Pertsemlidis, Alexander, primary

Published
2023
Full Text
View/download PDF

22. Data from Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling

Author

Borkowski, Robert, primary, Du, Liqin, primary, Zhao, Zhenze, primary, McMillan, Elizabeth, primary, Kosti, Adam, primary, Yang, Chin-Rang, primary, Suraokar, Milind, primary, Wistuba, Ignacio I., primary, Gazdar, Adi F., primary, Minna, John D., primary, White, Michael A., primary, and Pertsemlidis, Alexander, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 3 from Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling

Author

Borkowski, Robert, primary, Du, Liqin, primary, Zhao, Zhenze, primary, McMillan, Elizabeth, primary, Kosti, Adam, primary, Yang, Chin-Rang, primary, Suraokar, Milind, primary, Wistuba, Ignacio I., primary, Gazdar, Adi F., primary, Minna, John D., primary, White, Michael A., primary, and Pertsemlidis, Alexander, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 1 from Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling

Author

Borkowski, Robert, primary, Du, Liqin, primary, Zhao, Zhenze, primary, McMillan, Elizabeth, primary, Kosti, Adam, primary, Yang, Chin-Rang, primary, Suraokar, Milind, primary, Wistuba, Ignacio I., primary, Gazdar, Adi F., primary, Minna, John D., primary, White, Michael A., primary, and Pertsemlidis, Alexander, primary

Published
2023
Full Text
View/download PDF

35. Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer

Author

Gomez, Daniel Richard, primary, Byers, Lauren Averett, additional, Nilsson, Monique, additional, Diao, Lixia, additional, Wang, Jing, additional, Li, Lerong, additional, Tong, Pan, additional, Hofstad, Mia, additional, Saigal, Babita, additional, Wistuba, Ignacio, additional, Kalhor, Neda, additional, Swisher, Stephen, additional, Fan, Youhong, additional, Hong, Waun Ki, additional, Suraokar, Milind, additional, Behrens, Carmen, additional, Moran, Cesar, additional, and Heymach, John Victor, additional

Published
2018
Full Text
View/download PDF

37. Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

Author

Aramburu, Ander, primary, Zudaire, Isabel, additional, Pajares, María J., additional, Agorreta, Jackeline, additional, Orta, Alberto, additional, Lozano, María D., additional, Gúrpide, Alfonso, additional, Gómez-Román, Javier, additional, Martinez-Climent, Jose A., additional, Jassem, Jacek, additional, Skrzypski, Marcin, additional, Suraokar, Milind, additional, Behrens, Carmen, additional, Wistuba, Ignacio I., additional, Pio, Ruben, additional, Rubio, Angel, additional, and Montuenga, Luis M., additional

Published
2015
Full Text
View/download PDF

38. Abstract 3623: Neoadjuvant chemotherapy is associated with increased expression of DNA repair proteins and epithelial to mesenchymal transition (EMT) in patients with non-small cell lung cancer (NSCLC)

Author

Gomez, Daniel R., primary, Diao, Lixia, additional, Wang, Jing, additional, Wistuba, Ignacio I., additional, Moran, Cesar, additional, Kalhor, Neda, additional, Suraokar, Milind B., additional, Swisher, Stephen G., additional, Behrens, Carmen, additional, Fan, Youhong, additional, Heymach, John V., additional, and Byers, Lauren A., additional

Published
2015
Full Text
View/download PDF

40. Genetic Mutation of p53 and Suppression of the miR-17∼92 Cluster Are Synthetic Lethal in Non–Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling

Author

Borkowski, Robert, primary, Du, Liqin, additional, Zhao, Zhenze, additional, McMillan, Elizabeth, additional, Kosti, Adam, additional, Yang, Chin-Rang, additional, Suraokar, Milind, additional, Wistuba, Ignacio I., additional, Gazdar, Adi F., additional, Minna, John D., additional, White, Michael A., additional, and Pertsemlidis, Alexander, additional

Published
2015
Full Text
View/download PDF

41. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

Author

Chen, Limo, primary, Gibbons, Don L., additional, Goswami, Sangeeta, additional, Cortez, Maria Angelica, additional, Ahn, Young-Ho, additional, Byers, Lauren A., additional, Zhang, Xuejun, additional, Yi, Xiaohui, additional, Dwyer, David, additional, Lin, Wei, additional, Diao, Lixia, additional, Wang, Jing, additional, Roybal, Jonathon D., additional, Patel, Mayuri, additional, Ungewiss, Christin, additional, Peng, David, additional, Antonia, Scott, additional, Mediavilla-Varela, Melanie, additional, Robertson, Gordon, additional, Jones, Steve, additional, Suraokar, Milind, additional, Welsh, James W., additional, Erez, Baruch, additional, Wistuba, Ignacio I., additional, Chen, Lieping, additional, Peng, Di, additional, Wang, Shanshan, additional, Ullrich, Stephen E., additional, Heymach, John V., additional, Kurie, Jonathan M., additional, and Qin, F. Xiao-Feng, additional

Published
2014
Full Text
View/download PDF

44. VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy

Author

Riquelme, Erick, primary, Suraokar, Milind, additional, Behrens, Carmen, additional, Lin, Heather Y., additional, Girard, Luc, additional, Nilsson, Monique B., additional, Simon, George, additional, Wang, Jing, additional, Coombes, Kevin R., additional, Lee, J. Jack, additional, Hong, Waun Ki, additional, Heymach, John, additional, Minna, John D., additional, and Wistuba, Ignacio I., additional

Published
2014
Full Text
View/download PDF

45. Regulation of tumor cell PD-L1 expression by microRNA-200 and control of lung cancer metastasis.

Author

Gibbons, Don Lynn, primary, Chen, Limo, additional, Goswami, Sangeeta, additional, Cortez, Maria Angelica, additional, Ahn, Young-Ho, additional, Byers, Lauren Averett, additional, Lin, Wei, additional, Diao, Lixia, additional, Wang, Jing, additional, Roybal, Jonathon, additional, Ungewiss, Christin, additional, Antonia, Scott Joseph, additional, Mediaville-Varela, Melanie, additional, Suraokar, Milind B., additional, Welsh, James, additional, Chen, Lieping, additional, Wistuba, Ignacio Ivan, additional, Heymach, John, additional, Kurie, Jonathan M., additional, and Qin, Frank Xiao-Feng, additional

Published
2014
Full Text
View/download PDF

46. Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer

Author

Delgado, Oliver, primary, Batten, Kimberly G., additional, Richardson, James A., additional, Xie, Xian-Jin, additional, Gazdar, Adi F., additional, Kaisani, Aadil A., additional, Girard, Luc, additional, Behrens, Carmen, additional, Suraokar, Milind, additional, Fasciani, Gail, additional, Wright, Woodring E., additional, Story, Michael D., additional, Wistuba, Ignacio I., additional, Minna, John D., additional, and Shay, Jerry W., additional

Published
2014
Full Text
View/download PDF

47. BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation

Author

Yao, Yixin, Suraokar, Milind, Darnay, Bryant, Hollier, Brett, Shaiken, Tattym, Asano, Takayuki, Chen, Chien-Hung, Chang, Benny, Lu, Yiling, Mills, Gordon, Sarbassov, Dos, Mani, Sendurai, Abbruzzese, James, Reddy, Shrikanth, Yao, Yixin, Suraokar, Milind, Darnay, Bryant, Hollier, Brett, Shaiken, Tattym, Asano, Takayuki, Chen, Chien-Hung, Chang, Benny, Lu, Yiling, Mills, Gordon, Sarbassov, Dos, Mani, Sendurai, Abbruzzese, James, and Reddy, Shrikanth

Abstract

Phosphorylation and activation of Akt1 is a crucial signaling event that promotes adipogenesis. However, neither the complex multistep process that leads to activation of Akt1 through phosphorylation at Thr308 and Ser473 nor the mechanism by which Akt1 stimulates adipogenesis is fully understood. We found that the BSD domain–containing signal transducer and Akt interactor (BSTA) promoted phosphorylation of Akt1 at Ser473 in various human and murine cells, and we uncovered a function for the BSD domain in BSTA-Akt1 complex formation. The mammalian target of rapamycin complex 2 (mTORC2) facilitated the phosphorylation of BSTA and its association with Akt1, and the BSTA-Akt1 interaction promoted the association of mTORC2 with Akt1 and phosphorylation of Akt1 at Ser473 in response to growth factor stimulation. Furthermore, analyses of bsta gene-trap murine embryonic stem cells revealed an essential function for BSTA and phosphorylation of Akt1 at Ser473 in promoting adipocyte differentiation, which required suppression of the expression of the gene encoding the transcription factor FoxC2. These findings indicate that BSTA is a molecular switch that promotes phosphorylation of Akt1 at Ser473 and reveal an mTORC2-BSTA-Akt1-FoxC2–mediated signaling mechanism that is critical for adipocyte differentiation.

Published
2013

48. Abstract 5589: Molecular signatures of in vitro drug response in lung cancer.

Author

Girard, Luc, primary, Peyton, Michael, additional, Wistuba, Ignacio, additional, Xie, Yang, additional, Greer, Rachel, additional, Suraokar, Milind B., additional, Behrens, Carmen, additional, Xiao, Guanghua, additional, Heymach, John, additional, Wheeler, David A., additional, Davis, Caleb F., additional, Huffman, Kenneth, additional, Shames, David S., additional, Coombes, Kevin R., additional, Gazdar, Adi F., additional, Lam, David CL, additional, Beer, David G., additional, and Minna, John D., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results